Cancer News
OncoLink Cancer News - HealthDay


EGCG Treatment May Be Useful for Chronic Leukemia

-- Eric Metcalf

Friday, June 5, 2009

FRIDAY, June 5 (HealthDay News) -- An oral preparation of epigallocatechin-3-gallate (EGCG) with Polyphenon E appeared to be well tolerated and provided clinical activity in patients with chronic lymphocytic leukemia (CLL), according to research published online May 26 in the Journal of Clinical Oncology.

Tait D. Shanafelt, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues analyzed data from a Phase I trial involving 33 patients with Rai stage 0 to II CLL given varying doses of Polyphenon E capsules, containing EGCG.

The researchers found that the treatment appeared to be well tolerated, with common side effects including transaminitis (in 11 patients, all grade 1), abdominal pain (grade 1 in 10 patients and grade 3 in one patient) and nausea (grade 1 in 13 patients and grade 2 in three patients). One patient showed a partial remission, 11 patients had at least a 20 percent sustained reduction in absolute lymphocyte count, and overall, 18 patients fulfilled the criteria for a biologic response.

"Despite extensive data demonstrating that 50 to 70 percent of patients with asymptomatic, earlier stage CLL will progress and require treatment, such patients are presently managed with observation. The phase I data presented here suggest that Polyphenon E may have clinical activity in these patients and the fact that this treatment is very well tolerated suggests Polyphenon E merits additional evaluation as a disease stabilizing agent," the authors conclude.

Polyphenon E International provided support for the study.

Abstract
Full Text (subscription or payment may be required)

Specialties Cardiology
Diabetes & Endocrinology
Internal Medicine
Family Practice

Copyright © 2009 ScoutNews, LLC. All rights reserved.


I Wish You Knew

How an oncology social worker can improve your cancer experience

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More